Skip to content

A Randomized Controlled Clinical Study on the Treatment of Chronic Fatigue Syndrome with Xuefu Zhuyu Jiajian Decoction.

A Randomized Controlled Clinical Study on the Treatment of Chronic Fatigue Syndrome with Xuefu Zhuyu Jiajian Decoction.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001281
Enrollment
Unknown
Registered
2026-05-26
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Fatigue Syndrome

Interventions

Experimental Group:Xuefu Zhuyu Jiajian Formula Granules, twice daily, 1 packet each time, dissolve in warm water. Take continuously for a 28-day period.
Control Group:Placebo, made from maltodextrin, taken twice daily, one packet each time, dissolved in warm water. Continue for 28 consecutive days.

Sponsors

Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for chronic fatigue syndrome. (2) Age between 18 and 65 years, with no restriction on gender. (3) Voluntarily participates in this research study and signs the informed consent form. All individuals who meet all of the above criteria will be included.

Exclusion criteria

Exclusion criteria: (1) Other clearly diagnosed diseases causing chronic fatigue: such as malignant tumors, heart failure, chronic obstructive pulmonary disease, stroke, multiple sclerosis, and other severe cardiovascular and cerebrovascular diseases; infectious diseases; rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus; endocrine system diseases such as hypothyroidism, hypopituitarism, and adrenal insufficiency; severe obesity (BMI > 40 kg/m²). (2) Confirmed severe anxiety or depressive disorders: Hamilton Anxiety Scale score = 28 points, Hamilton Depression Scale-17 score = 24 points. (3) Patients in pregnancy, lactation, or with mental disorders who cannot cooperate with this study. (4) Patients currently participating in other clinical studies. Any of the above criteria can result in exclusion.

Design outcomes

Primary

MeasureTime frame
Fatigue Symptom Scale-14 Scoring;

Secondary

MeasureTime frame
CFS Clinical Symptom Severity Scoring Scale;Fatigue Asessment Instrument;

Countries

China

Contacts

Public ContactMiao Wang

Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

wangmiao_126@126.com13564364477

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026